Addressing the challenges in forensic drug chemistry II

Brandt, Simon D.; Collins, Michael

doi:10.1002/dta.3223

Cited by 1 publication

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Forensic drug testing labs are continuously challenged by analyzing and identifying “atypical” substances 1–4 . For the well‐established controlled substances, knowledge of analytical behavior, reference material and data, and validated analytical methods are available in each forensic laboratory.…”

Section: Introductionmentioning

confidence: 99%

“…Forensic drug testing labs are continuously challenged by analyzing and identifying "atypical" substances. [1][2][3][4] For the well-established controlled substances, knowledge of analytical behavior, reference material and data, and validated analytical methods are available in each forensic laboratory. In contrast, new psychoactive substances (NPS) and additional unusual substances, that is, pure (designer) pharmaceuticals, (designer) doping agents, and drug or pharmaceutical precursors, seized within the casework of police and customs authorities pose challenges in forensic drug analysis and assessment.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS

Pulver

Fischmann²,

Westphal³

et al. 2022

Drug Testing and Analysis

View full text Add to dashboard Cite

Novel substances for which none or limited analytical data are available constitute a challenge for police and customs forensic laboratories. The time-consuming process of structural elucidation and acquisition of analytical data has been centralized in the ADEBAR project in Germany, co-funded since 2017 by the EU's Internal Security Fund. The project aims to comprehensively characterize substances relevant for forensic-toxicological casework within the analytical competence network. The analytical datasets are distributed digitally through European and (inter)national channels.Additionally, pharmacological evaluation allows for estimating in vivo potency and potential harm required as scientific evidence for legislative amendments. The ADEBAR project contributes to the availability of analytical data on new substances relevant to the daily work of police and customs laboratories. Since the inception of Svenja Fischmann and Benedikt Pulver contributed equally to this work.

show abstract

Section: Introductionmentioning

confidence: 99%